BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1580 related articles for article (PubMed ID: 35125087)

  • 21. New halogenated constituents from Mangifera zeylanica Hook.f. and their potential anti-cancer effects in breast and ovarian cancer cells.
    Ediriweera MK; Tennekoon KH; Adhikari A; Samarakoon SR; Thabrew I; de Silva ED
    J Ethnopharmacol; 2016 Aug; 189():165-74. PubMed ID: 27224244
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Yırtıcı Ü; Ergene A; Adem Ş; Atalar MN; Eyüpoğlu V; Rawat R; Arat E; Hamzaoğlu E
    J Biomol Struct Dyn; 2024 Mar; 42(5):2341-2357. PubMed ID: 37098809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and Anticancer Activity of a Novel Phenolic Compound from
    Darwati D; Safitri AN; Ambardhani N; Mayanti T; Nurlelasari N; Kurnia D
    Drug Des Devel Ther; 2021; 15():3523-3533. PubMed ID: 34408404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer Activity and In Silico ADMET Properties of 2,4,5-Trisubstitutedthiazole Derivatives.
    Al-Jaidi BA; Telfah ST; Bardaweel SK; Deb PK; Borah P; Venugopala KN; Bataineh YA; Al Khames Aga QA
    Curr Drug Metab; 2021; 22(7):532-536. PubMed ID: 33334285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
    Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
    Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LC-MS characterized methanolic extract of zanthoxylum armatum possess anti-breast cancer activity through Nrf2-Keap1 pathway: An in-silico, in-vitro and in-vivo evaluation.
    Sahu R; Kar RK; Sunita P; Bose P; Kumari P; Bharti S; Srivastava S; Pattanayak SP
    J Ethnopharmacol; 2021 Apr; 269():113758. PubMed ID: 33359860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GC/MS Analysis, Cytotoxicity, and Antiviral Activities of
    Soleman DM; Eldahshan OA; Ibrahim MH; Ogaly HA; Galal HM; Batiha GE; Elkousy RH
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838616
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of Anticancer and Antioxidant phytoconstituents from chloroform fraction of Solanum nigrum L. berries using GC-MS/MS analysis.
    Khan HJ; Ahmad MK; Khan AR; Rastogi N; Mahdi AA; Ansari JA; Fatima N; Satyanarayan GNV
    Indian J Exp Biol; 2016 Nov; 54(11):774-82. PubMed ID: 30179424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study.
    Salem MG; El-Maaty DMA; El-Deen YIM; Elesawy BH; Askary AE; Saleh A; Saied EM; Behery ME
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiproliferative Activity of
    Siddiqui S; Zia Q; Abbas M; Verma S; Jafri A; Misra D; Luqman S; Ahamed M; Ahmad MS; Arshad M
    Anticancer Agents Med Chem; 2021; 21(18):2536-2545. PubMed ID: 33568037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Indazol-Pyrimidine-Based Derivatives as Selective Anticancer Agents: Design, Synthesis, and In Silico Studies.
    Al-Tuwaijri HM; Al-Abdullah ES; El-Rashedy AA; Ansari SA; Almomen A; Alshibl HM; Haiba ME; Alkahtani HM
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach.
    Paul D; Mahanta S; Tag H; Das SK; Das Gupta D; Tanti B; Ananthan R; Das R; Jambhulkar S; Hui PK
    Mol Divers; 2022 Aug; 26(4):1933-1955. PubMed ID: 34554395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidant and anticancer potential of ethyl acetate extract of bark and flower of Tecoma stans (Linn) and In Silico studies on phytoligands against Bcl 2 and VEGFR2 factors.
    Narayanan M; Gothandapani A; Venugopalan R; Rethinam M; Pitchai S; Alahmadi TA; Almoallim HS; Kandasamy S; Brindhadevi K
    Environ Res; 2023 Aug; 231(Pt 1):116112. PubMed ID: 37182829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-silico method for elucidation of prodigiosin as PARP-1 inhibitor a prime target of Triple-negative breast cancer.
    Sundararajan P; Dharmaraj Rajaselvi D; Vivekananthan S; Priya Ramasamy S
    Bioorg Chem; 2023 Sep; 138():106618. PubMed ID: 37244231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic effects of extracts obtained from plants of the Oleaceae family: bio-guided isolation and molecular docking of new secoiridoids from
    Mansour KA; Elbermawi A; Al-Karmalawy AA; Lahloub MF; El-Neketi M
    Pharm Biol; 2022 Dec; 60(1):1374-1383. PubMed ID: 35961303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait.
    Iqbal D; Khan MS; Khan MS; Ahmad S; Hussain MS; Ali M
    Lipids Health Dis; 2015 Mar; 14():15. PubMed ID: 25884722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.
    Lu Y; Yin W; Alam MS; Kadi AA; Jahng Y; Kwon Y; Rahman AFMM
    Anticancer Agents Med Chem; 2020; 20(4):464-475. PubMed ID: 31763968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation, Characterization and Anticancer Potential of Cytotoxic Triterpenes from Betula utilis Bark.
    Mishra T; Arya RK; Meena S; Joshi P; Pal M; Meena B; Upreti DK; Rana TS; Datta D
    PLoS One; 2016; 11(7):e0159430. PubMed ID: 27453990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiproliferative, apoptosis-inducing activity and molecular docking studies of sydnones compounds.
    Hossain SL; Mathews M; Bhyranalyar Nagarajappa VS; Kumar BK; Veerappa Yelamaggad CV; Singh CR
    J Cancer Res Ther; 2022; 18(3):681-690. PubMed ID: 34708812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.